Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Treatment naive chronically infected subjects with Hepatitis C Virus genotype 1
HCV RNA viral load of ≤10\*5\* IU/mL (100,000 IU/mL)
Body Mass Index (BMI) of 18 to 35 kg/m², inclusive
You may not be if
Women who are pregnant or breast feeding
Any significant acute or chronic medical illness which is not stable or is not controlled with medication or is not consistent with Hepatitis C infection
Any other medical, psychiatric and/or social reason which, in the opinion of the Investigator, would make the candidate inappropriate for participation in this study
Clareo Health | Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus
